Actinium Pharmaceuticals, Inc. 4
4 · Actinium Pharmaceuticals, Inc. · Filed Sep 1, 2016
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2016-08-30$1.81/sh−300$545→ 4,846,514 total - Sale
Common Stock
2016-08-31$1.81/sh−6,400$11,584→ 4,814,826 total - Sale
Common Stock
2016-08-31$1.85/sh−40,200$74,370→ 4,733,526 total - Sale
Common Stock
2016-08-31$1.86/sh−9,800$18,228→ 4,723,726 total - Sale
Common Stock
2016-08-30$1.80/sh−1,500$2,708→ 4,877,488 total - Sale
Common Stock
2016-08-31$1.82/sh−25,100$45,682→ 4,789,526 total - Sale
Common Stock
2016-08-30$1.81/sh−30,474$55,158→ 4,847,014 total - Sale
Common Stock
2016-08-30$1.82/sh−100$182→ 4,846,414 total - Sale
Common Stock
2016-08-31$1.81/sh−200$363→ 4,814,626 total - Sale
Common Stock
2016-08-31$1.83/sh−800$1,464→ 4,788,726 total - Sale
Common Stock
2016-08-30$1.80/sh−23,500$42,300→ 4,878,988 total - Sale
Common Stock
2016-08-30$1.81/sh−200$363→ 4,846,814 total - Sale
Common Stock
2016-08-31$1.80/sh−25,188$45,338→ 4,821,226 total - Sale
Common Stock
2016-08-31$1.84/sh−15,000$27,600→ 4,773,726 total - Sale
Common Stock
2016-08-31$1.87/sh−14,165$26,489→ 4,709,561 total